Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 6/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 3/20 | 0.40 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.39 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.37 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.37 |
| ▸ | HSD17B3 | P37058 | 4/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10018136 | 1.00 | GPR35 (0.49) | GPR35CA2ELANEPLA2G4ACYSLTR2 | |
| SCHEMBL10144491 | 0.86 | GPR35 (0.57) | GPR35CA2ELANEPLA2G4AHSD17B3 | |
| SCHEMBL1156737 | 0.83 | CA2 (0.45) | GPR35CA2PLA2G4AHSD17B3 | |
| SCHEMBL1363701 | 0.83 | CES2 (0.47) | GPR35PLA2G4AHSD17B3 | |
| SCHEMBL1365090 | 0.83 | CES2 (0.47) | GPR35PLA2G4AHSD17B3 | |
| SCHEMBL1364678 | 0.83 | CES2 (0.47) | GPR35PLA2G4AHSD17B3 | |
| SCHEMBL14647663 | 0.79 | GPR35 (0.46) | GPR35CYSLTR2CYSLTR1 | |
| SCHEMBL14647690 | 0.79 | GPR35 (0.46) | GPR35CYSLTR2CYSLTR1 | |
| SCHEMBL1156975 | 0.75 | GPR35 (0.53) | GPR35CYSLTR2CYSLTR1 | |
| SCHEMBL1156982 | 0.75 | GPR35 (0.53) | GPR35CYSLTR2CYSLTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9166167-B2 | P-type materials and organic electronic devices | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-10-20 | — | — | US | disclosed |
| US-20120161117-A1 | P-TYPE MATERIALS AND ORGANIC ELECTRONIC DEVICES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120161117-A1 | P-TYPE MATERIALS AND ORGANIC ELECTRONIC DEVICES | POP1, CACNA1A, PNN | GPR35 4807/4885CA2 3234/4885ELANE 2740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.